Brevan Howard Capital Management LP disclosed 36 US equity positions worth $136.7m in its Q2 2022 13F filing. Its largest position is MRNA at 29.3% of the reported book, followed by URA and CME. Versus Q1 2022 it opened 23 new positions, added to 7, reduced 1 and exited 12.
$137m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
36
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
29.3%
Largest position
The largest single position as a share of the reported equity book.
86.1%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
6
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
40
Quarters on file since Q3 2013
Quarters for which this manager's 13F holdings are on record.